TW200640479A - Composition of Chinese medicine - Google Patents
Composition of Chinese medicineInfo
- Publication number
- TW200640479A TW200640479A TW094117675A TW94117675A TW200640479A TW 200640479 A TW200640479 A TW 200640479A TW 094117675 A TW094117675 A TW 094117675A TW 94117675 A TW94117675 A TW 94117675A TW 200640479 A TW200640479 A TW 200640479A
- Authority
- TW
- Taiwan
- Prior art keywords
- vitamin
- ginsenoside
- composition
- chinese medicine
- acid
- Prior art date
Links
Abstract
The present invention relates to a composition of Chinese medicine used for treating diabetes, and the main formula is the recipe consisting of: ginsenoside Rb1, ginsenoside Rb2, American ginsenoside, Chinese ladiestresses root, whorledleaf Solomonseal Rhizome, lecithin, propolis, Indian Buead, Job's tears, Jerusalem artichoke, Vitamin A, Vitamin D, Vitamin E, Vitamin K1, Vitamin C, Vitamin B1, Vitamin B2, Vitamin B6, Vitamin B12, nicotinic acid, folic acid, pantothenic acid, alkaloid, choline, inositol, iron, iodine, zinc, selenium, chromium, manganese, copper, vanadium, sodium, potassium, calcium, phosphorous, and magnesium.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW094117675A TW200640479A (en) | 2005-05-30 | 2005-05-30 | Composition of Chinese medicine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW094117675A TW200640479A (en) | 2005-05-30 | 2005-05-30 | Composition of Chinese medicine |
Publications (1)
Publication Number | Publication Date |
---|---|
TW200640479A true TW200640479A (en) | 2006-12-01 |
Family
ID=57809882
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW094117675A TW200640479A (en) | 2005-05-30 | 2005-05-30 | Composition of Chinese medicine |
Country Status (1)
Country | Link |
---|---|
TW (1) | TW200640479A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110229587A1 (en) * | 2009-09-24 | 2011-09-22 | Algaecal Distribution Inc. | Calcium Supplements for the Treatment of Diabetes |
US9308222B2 (en) | 2008-01-28 | 2016-04-12 | Yun Kau Tam | Formulas comprising highly soluble elements and vitamins for the prevention and amelioration of osteoporosis |
CN114748567A (en) * | 2022-03-29 | 2022-07-15 | 福州和杏健康管理服务有限公司 | Blood sugar reducing composition containing antrodia camphorata and preparation method and application thereof |
-
2005
- 2005-05-30 TW TW094117675A patent/TW200640479A/en unknown
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9308222B2 (en) | 2008-01-28 | 2016-04-12 | Yun Kau Tam | Formulas comprising highly soluble elements and vitamins for the prevention and amelioration of osteoporosis |
US20110229587A1 (en) * | 2009-09-24 | 2011-09-22 | Algaecal Distribution Inc. | Calcium Supplements for the Treatment of Diabetes |
CN114748567A (en) * | 2022-03-29 | 2022-07-15 | 福州和杏健康管理服务有限公司 | Blood sugar reducing composition containing antrodia camphorata and preparation method and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2015007479A (en) | Ppar-sparing thiazolidinediones and combinations for the treatment of neurodegenerative diseases. | |
HRP20140398T4 (en) | Use of one or a combination of phyto-cannabinoids in the treatment of epilepsy | |
DOP2012000057A (en) | NEW ANTIGONISTS OF PYRIMIDINHEPCIDINE AND TRIAZINHEPCIDINE | |
WO2008079291A3 (en) | Substituted heterocycles and methods of use | |
MX2012004525A (en) | Compounds. | |
JOP20180036A1 (en) | Novel ferroportin-inhibitor salts | |
WO2017068089A3 (en) | Ferroportin inhibitors | |
TW200724532A (en) | Pyrimidinecarboxylic acid derivatives and their use | |
UA96441C2 (en) | Pharmaceutical composition comprosing thiazolidinedione analogues for the treatment of metabolic inflammation mediated disease | |
TW200745003A (en) | Novel compounds | |
MX2009008531A (en) | Nitrogen-containing heterocyclyl ketones and methods of use. | |
MX2009010407A (en) | Fluorinated derivatives of deferiprone. | |
MY156780A (en) | Substituted aromatic compounds and pharmaceutical uses thereof | |
NZ600390A (en) | Ppar-sparing thiazolidinedione salts for the treatment of metabolic diseases | |
HRP20050742A2 (en) | 3-methyl-2-(3-(2-phenyl-oxazol-4-ylmethoxy)-cyclohexanecarbonyl-amino butyric acid derivatives and related compounds as ppar modulators for the treatment of type 2 diabetes and atherosclerosis | |
PH12015500860A1 (en) | 2-phenyl -5- heterocyclyl -tetrahydro-2h- pyran-3-amine compounds for use in the treatment of diabetes and its associated disorders | |
WO2011017054A3 (en) | Prodrugs of desazadesferrothiocin polyether analogues as metal chelation agents | |
MX2011006006A (en) | Compounds, pharmaceutical composition and methods for use in treating metabolic disorders. | |
EP2257161A4 (en) | Ahcy hydrolase inhibitors for treatment of hyper homocysteinemia | |
TW200640479A (en) | Composition of Chinese medicine | |
Uen et al. | Inhibition of aqueous extracts of Solanum nigrum (AESN) on oral cancer through regulation of mitochondrial fission | |
UA75461U (en) | Medicine for the prevention of dental diseases | |
HK1138264A1 (en) | Aminoalkoxy aryl sulfonamide compounds and their use as 5-ht6 ligands | |
MX2009013482A (en) | [1,10]-phenanthroline derivatives for the treatment of neurodegenerative or haematological diseases. | |
HRP20050739A2 (en) | Cycloalkyl-substituted alkanoic acid derivatives, methods for the production thereof, and use thereof as a medicament |